Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate
the immune system and stop tumor cells from growing.
PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating
patients with basal cell skin cancer.